Determinants of Red Cell Survival and Erythropoietic Activity in Patients with Sickle Cell Anemia in the Steady State

References

• Serjeant G. R. Fetal haemoglobin in homozygous sickle cell disease. Clin. Haematol. 1975; 4: 109–122
   PubMedGoogle Scholar
• Embury S. H., Dozy A. M., Miller J., Davis J. R., Kleman K. M., Preister H., Vichinsky E., Lande W., Lubin B., Kan Y. W., Mentzer W. C. Concurrent sickle‐cell anemia and α thalassemia. N. Engl. J. Med. 1982; 306: 270–274
   PubMed Web of Science ®Google Scholar
• De Ceulaer K., Higgs D. R., Hayes R. J., Serjeant R. E., Serjeant G. R. α‐Thalassemia reduces the hemolytic rate in homozygous sickle cell disease. N. Engl. J. Med. 1983; 309: 189–193
   PubMed Web of Science ®Google Scholar
• Ballas S. K., Larner J., Smith E. D., Surrey S., Schwartz E., Rappaport E. Rheolog‐ical predictors of the severity of the painful sickle cell crisis. Blood 1988; 72: 1216–1223
   PubMed Web of Science ®Google Scholar
• Steinberg M. H., Rosenstock W., Coleman M. B., Adams J. G., Platica O., Cedeno M., Rieder R. F., Wilson J. T., Milner P., West S. Effects of thalassemia and microcytosis on the hematologic and vasocclusive severity of sickle cell anemia. Blood 1984; 63: 1353–1360
   PubMed Web of Science ®Google Scholar
• Stevens M. C. G., Maude G. H., Beckford M., Grandison Y., Mason K., Taylor B., Serjeant B. E., Higgs D. R., Teal H., Weatherall D. J., Serjeant G. R. a Thalassemia and the hematology of homozygous sickle cell disease in childhood. Blood 1986; 67: 411–414
   PubMed Web of Science ®Google Scholar
• Higgs D. R., Aldridge B. E., Lamb J., Clegg J. B., Weatherall D. J., Hayes R. J., Grandison Y., Lowrie Y., Mason K. P., Serjeant B. E., Sergeant G. R. The interaction of α‐thalassemia and homozygous sickle‐cell disease. N. Engl. J. Med. 1982; 306: 1441–1446
   PubMed Web of Science ®Google Scholar
• Castro O., Haddy T. B. Improved survival of iron‐deficient patients with sickle erythrocytes. N. Engl. J. Med. 1983; 308: 527
   PubMedGoogle Scholar
• Charache S., Terrin M. L., Moore R. D., Dover G. J., Barton F. B., Eckert S. V., McMa‐hon R. P., Bonds D. R., the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 1995; 332: 1317–1322
   PubMed Web of Science ®Google Scholar
• Ballas S. K., Marcolina M. J., Dover G. J., Barton F. B. Erythropoietic activity in patients with sickle cell anemia before and after treatment with hydroxyurea. Br. J. Haematol. 1999; 105: 491–496
   PubMed Web of Science ®Google Scholar
• International Committee for Standardization in Hematology. Recommended method for radioisotope red‐cell survival studies. Br. J. Haematol. 1980; 45: 659–666
   PubMedGoogle Scholar
• Engstedt L. Endogenous formation of carbon monoxide in hemolytic disease. ActaMed. Scand. 1957; 159(Suppl 332)22
   Google Scholar
• Erslev A. J. Erythrokinetics. Hemutology2nd edition, J. W. Williams, E. Beutler, A. J. Erslev, R. W. Rundles. McGraw Hill, Inc., New York, NYUSA 1977; 1620–1626
   Google Scholar
• Cazzola M., Huebers H. A., Sayers M. H., Macphail A. P., Eng M., Finch C. A. Transferrin saturation, plasma. iron turnover and transferrin uptake in normal humans. Blood 1985; 66: 1935–939
   Google Scholar
• Cazzola M., Pootrakul P., Huebers H. A., Eng M., Eschbach J., Finch C. A. Eryth‐roid marrow function in anemic patients. Blood 1987; 69: 296–301
   PubMed Web of Science ®Google Scholar
• Betke K., Marti H. R., Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature 1959; 184: 1877–1878
   PubMed Web of Science ®Google Scholar
• Sherwood J. B., Goldwasser E., Chilcote R., Carmichael L. D., Nagel R. Sickle cell anemia patients have low erythropoietin levels fortheir degree of anemia. Blood 1986; 67: 46–49
   PubMed Web of Science ®Google Scholar
• Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 1975; 98: 503–517
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Begelstein B. A technique for radiolabelling DNA restriction endonu‐clease fragments to high specific activity. Anal. Biochem. 1983; 132: 6–13
   PubMed Web of Science ®Google Scholar
• Antonarakis S. E., Boehm C. D., Serjeant G. R., Theisen C. E., Dover G. J., Kazazian H. H., Jr. Origin of the βs‐globin gene in Blacks: the contribution of recurrent mutation or gene conversion or both. Proc. Natl. Acad. Sci. USA 1984; 81: 853–856
   PubMed Web of Science ®Google Scholar
• Ballas S. K., Talacki C. A., Adachi K., Schwartz E., Surrey S., Rappaport E. The XmnI site (‐158, C→T) 5′ to the Gγ globin: correlation with the Senegalese haplotype and Gγ globin expression. Hemoglobin. 1991; 15: 393–405
   PubMed Web of Science ®Google Scholar
• Wilkinson L. Systat: the system for statistics. Systat, Inc., Evanston, ILUSA 1986
   Google Scholar
• Nagel R. L., Erlingsson S., Fabry M. E., Croizat H., Sunka S. M., Lachman H., Sutton M., Driscoll C., Bouhassira E., Billett H. H. The Senegal DNA haplotype is associated with the amelioration of anemia in African American sickle cell anemia patients. Blood 1991; 77: 1371–1375
   PubMed Web of Science ®Google Scholar
• Powars D. R., Chan L., Schroeder W. A. βS‐Gene‐cluster haplotypes in sickle cell anemia: clinical implications. Am. J. Pediatr. Hematol. Oncol. 1990; 12: 367–374
   PubMedGoogle Scholar
• Powars D. R., Chan L., Schroeder W. A. The variable expression of sickle cell disease is genetically determined. Semin. Hematol. 1990; 27: 360–376
   PubMed Web of Science ®Google Scholar
• Powars D. R., Elliot‐Mills D. D., Chan L., Niland J., Hiti A. L., Opas L. M., Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann. Intern. Med. 1991; 115: 614–620
   PubMed Web of Science ®Google Scholar
• Polenakovic M., Sikole A. Is erythropoietin a survival factor for red blood cells?. J. Am. Soc. Nephrol. 1996; 7: 1178–1182
   PubMed Web of Science ®Google Scholar